YahooAugust 11, 2026 at 5:41 AM NY24 days ago
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill1 hour ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill2 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo2 hours ago
Sector Update: Financial
Yahoo3 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo3 hours ago